Biodesix (BDSX) Non Operating Income (2023 - 2026)

Biodesix (BDSX) has 4 years of Non Operating Income data on file, last reported at -$1.6 million in Q1 2026.

• Quarterly Non Operating Income rose 18.98% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.0 million (up 10.07% YoY) and the FY2025 annual result came in at -$7.4 million, up 12.34% from the prior year.
• Non Operating Income climbed to -$1.6 million in Q1 2026, from -$2.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of -$1.6 million in Q1 2026 to a low of -$3.8 million in Q3 2023.
• A 4-year average of -$2.2 million and a median of -$2.0 million in 2025 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2024 — Non Operating Income soared 55.86% — and 2025, when it retreated 25.66%.
• Tracing BDSX's Non Operating Income over 4 years: stood at -$2.3 million in 2023, then grew by 29.4% to -$1.6 million in 2024, then retreated by 25.66% to -$2.0 million in 2025, then grew by 20.91% to -$1.6 million in 2026.
• The last three Non Operating Income figures came in at -$1.6 million (Q1 2026), -$2.0 million (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.